Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
N Engl J Med. 1991 Mar 21;324(12):781-8. doi: 10.1056/NEJM199103213241201.
N Engl J Med. 1991.
PMID: 1900101
Free article.
Clinical Trial.
The use of encainide and flecainide was discontinued because of excess mortality. We examined the mortality and morbidity after randomization to encainide or flecainide or their respective placebo. ...The mechanisms underlying the excess mortality …
The use of encainide and flecainide was discontinued because of excess mortality. We examined the mortality and morbidi …